Skip to main content
. 2020 Nov 24;13:1756284820974912. doi: 10.1177/1756284820974912

Figure 1.

Figure 1.

Second-line treatments after progression of disease.

5-FU, fluorouracil; CAPOX, capecitabine and oxaliplatin; FOLFIRI, folinic acid, 5-FU, and irinotecan; FOLFIRINOX, 5-FU, irinotecan, oxaliplatin, and folinic acid; FOLFOX, folinic acid, 5-FU, and oxaliplatin; LCV, leucovorin.